Sarah Wall, MD, talks about how it’s important to consider patient age when treating older patients with cancer because it will impact so many of them and blood cancers act differently and can be more aggressive in older adults.
With the population of older adults growing, it is becoming more important for providers to put attention on older adults, who are more likely to be diagnosed with cancer and in whom blood-based cancers function differently and more aggressively, explains Sarah Wall, MD, assistant professor in the Division of Hematology at The Ohio State University.
Transcript
Why is it important to study the relationship between age and hematological diseases and hematological cancers?
It's a really important question because it affects so many people, and I think that's the easy answer. In the US, the average age of the population is continuing to rise. The estimates are that by 2030, more than two-thirds of the population will be above the age of 60. Along with that, we would expect about 70% of those older adults to be diagnosed with a cancer because cancers are often diagnosed in older people related to changes that occur with age.
For blood cancers, in particular, it's also an important question because a lot of blood cancers behave differently in older adults. In acute myeloid leukemia, for example, there has been research looking at the differences in disease genetic markers, between patients younger than 60 and older than 60. Patients who are older than 60 with the same mutations as the younger group will behave differently and often will have more aggressive disease features. These are important things to take into consideration when you're treating these patients, that even though they may look the same by mutational status, the age may make a difference.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More